Although our research shows that over-expressed NR4A3 confines the anoikis resistance, migration and invasion of BLCA cells, it is still unknown whether NR4A3 can inhibit the malignant progress of BLCA in vivo. This evidence concerns the gene NR4A3 and bladder transitional cell carcinoma.